A New Technology for Simple, Cost-effective,
In-clinic Screening

The Vagus Device™ offers a simple, standardized, and user-friendly method for assessing autonomic function, making screening more efficient and accessible across multiple research fields. Our approved solution offers cost-effective and patient-centered detection of autonomic neuropathy, enabling early intervention and improved patient outcomes.

The Overlooked Impact of Autonomic Neuropathy
Autonomic Neuropathy (AN), a form of nerve inflammation, plays a critical role in various diseases, yet its detection remains complex and often overlooked in large-scale research and clinical practice. Today, 1 in 11 adults—approximately 463 million people—live with diabetes, with 10% of global healthcare expenditure dedicated to managing the disease. Annual costs reach $324 billion in the U.S. and $161 billion in Europe.

The Hidden Burden of AN in Diabetes
After 10 years of living with diabetes, up to 50% of patients develop AN. This condition significantly increases health risks, with patients facing a five-fold higher risk of mortality due to severe complications such as cardiac arrhythmias, silent myocardial ischemia, and sudden death. Additionally, AN is linked to other serious but preventable complications, including hypoglycemia, blood pressure instability, and sleep apnea.

The Urgent Need for Screening
Recognizing its impact, international guidelines recommend annual AN screening for all diabetes patients. While various diagnostic tools exist, current laboratory-based systems are often complex, costly, and inaccessible, limiting widespread adoption and early detection. Addressing these challenges with efficient, patient-friendly solutions is crucial for reducing preventable complications and improving long-term outcomes.

Validtated and in use:
With more than 40 peer-reviewed publications and adoption in over eight countries, our technology is trusted by leading pharmaceutical companies to refine and optimize drug development.

Streamline Patient Screenings:
The Vagus Device enables quick, comfortable assessments by in-clinic staff.

Enhance Diagnostic Precision:
The Vagus Device allows for the accurate, non-invasive diagnosis of autonomic neuropathy,aiding in the early and targeted intervention.

Boost Clinic Revenue and Save Time:
The Vagus Device improves clinic efficiency without significant overhead costs. Lowmaintenance and ease-of-use mean seamless integration into existing workflows.

Learn more at: VagusDevice.com